These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27746732)

  • 1. Patterns of Non-adherence to Supplementation with Calcium and Vitamin D in Persistent Postmenopausal Women Are Similar at Start and 1 Year Later: A Qualitative Longitudinal Study.
    Touskova T; Vytrisalova M; Palicka V; Hendrychova T; Chen YT; Fuksa L
    Front Pharmacol; 2016; 7():339. PubMed ID: 27746732
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug holidays: the most frequent type of noncompliance with calcium plus vitamin D supplementation in persistent patients with osteoporosis.
    Touskova T; Vytrisalova M; Palicka V; Hendrychova T; Fuksa L; Holcova R; Konopacova J; Kubena AA
    Patient Prefer Adherence; 2015; 9():1771-9. PubMed ID: 26719680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver JP; van den Bergh JP; Keown P; Sajjan S
    Osteoporos Int; 2018 Feb; 29(2):329-337. PubMed ID: 29110061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study.
    Misdrahi D; Tessier A; Husky M; Lange AC; Vrijens B; Llorca PM; Baylé FJ
    Schizophr Res; 2018 Mar; 193():114-118. PubMed ID: 28663027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence and persistence in patients with severe osteoporosis treated with teriparatide.
    Ziller V; Zimmermann SP; Kalder M; Ziller M; Seker-Pektas B; Hellmeyer L; Hadji P
    Curr Med Res Opin; 2010 Mar; 26(3):675-81. PubMed ID: 20078188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Hadji P; Papaioannou N; Gielen E; Feudjo Tepie M; Zhang E; Frieling I; Geusens P; Makras P; Resch H; Möller G; Kalouche-Khalil L; Fahrleitner-Pammer A
    Osteoporos Int; 2015 Oct; 26(10):2479-89. PubMed ID: 26018090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR; Shrader SP; Ragucci KR
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous bisphosphonates for post-menopausal osteoporosis: adherence to a network guideline.
    Yeh Y; Slovik D; Carter D; Clapp M; Churchill W; Reddy P
    J Clin Pharm Ther; 2011 Jun; 36(3):342-7. PubMed ID: 21545613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis.
    Halpern R; Becker L; Iqbal SU; Kazis LE; Macarios D; Badamgarav E
    J Manag Care Pharm; 2011; 17(1):25-39. PubMed ID: 21204588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Enhanced Exercise and Combined Vitamin D and Calcium Supplementation on Muscle Strength and Fracture Risk in Postmenopausal Chinese Women.
    Xue Y; Hu Y; Wang O; Wang C; Han G; Shen Q; Deng H; Jiang Y; Li M; Xia W; Xing X; Xu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Jun; 39(3):345-351. PubMed ID: 28695804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.
    Sayner R; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Giangiacomo AL; Tudor G; Sleath B
    Clin Ther; 2015 Sep; 37(9):1975-85. PubMed ID: 26164785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between the polymorphism of start codon and CDX2 site in vitamin D receptor gene and the effect of calcium supplementation on bone mineral density of postmenopausal women].
    Zhang ZL; He JW; Huang QR; Qin YJ; Hu YQ; Li M; Zhang H; Liu YJ; Hu WW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):397-401. PubMed ID: 16883525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an algorithm for analysing the electronic measurement of medication adherence in routine HIV care.
    Rotzinger A; Cavassini M; Bugnon O; Schneider MP
    Int J Clin Pharm; 2016 Oct; 38(5):1210-8. PubMed ID: 27473709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study in the Asia-Pacific Region (MUSIC OS-AP): Design of a multinational, prospective, observational study examining the impact of gastrointestinal events on osteoporosis management in postmenopausal women.
    Modi A; Ebeling PR; Lee MS; Min YK; Mithal A; Yang X; Sajjan S
    Bone Rep; 2015 Dec; 3():61-66. PubMed ID: 28377968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.
    Lai PS; Chua SS; Chew YY; Chan SP
    J Clin Pharm Ther; 2011 Oct; 36(5):557-67. PubMed ID: 21916908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a wireless handheld medication management device in the prevention of drug-drug interactions in a Medicaid population.
    Malone DC; Saverno KR
    J Manag Care Pharm; 2012; 18(1):33-45. PubMed ID: 22235953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis treatment in postmenopausal women after peripheral fractures: impact of information to general practitioners.
    Malochet-Guinamand S; Chalard N; Billault C; Breuil N; Ristori JM; Schmidt J
    Joint Bone Spine; 2005 Dec; 72(6):562-6. PubMed ID: 15996502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.